The Pfizer Clinical Research Unit is seeking healthy volunteers for a clinical trial of a study drug for atopic dermatitis. This study will assess how the study drug is tolerated and the amount in the body after being applied as cream or ointment.

Atopic dermatitis (AD) is one of the most common chronic inflammatory skin conditions. It causes a rash and itching and can negatively affect patients’ emotional well-being.

There is no cure for AD and, while available treatments may provide symptom relief, the community needs new long-term treatment options.

Card Summary Component

Who may participate

Joining a clinical trial is an important and personal decision. We hope it is one you will consider.

This study is seeking healthy adult volunteers, meaning that the participants will not have the condition being studied and are in overall good health. In addition to the criteria listed, participants must meet the following requirements:

  • Willing to have the study drug applied to their skin
  • No significant skin damage or abnormalities in areas that study drug may be applied (ie. large tattoos, scars, etc.)
  • *Female participants must be unable to bear children

There are other requirements for participation in this study. The study staff will explain these to you during the screening process.

 

Do you know someone who may meet these requirements? Refer a friend and you may be eligible to receive a bonus. 

Condition
Healthy

The disease, disorder, syndrome, illness, or injury that is being studied. On ClinicalTrials.gov, conditions may also include other health-related issues, such as lifespan, quality of life, and health risks.

Age
18-60 years

The age a person must be to participate in a clinical trial.

Sex
All sexes*

The sex of people who may participate in a clinical trial. Sex is a person’s classification based on assignment at birth. Eligibility based on sex is distinct from eligibility based on gender.

Referral bonus
Up to $150

Click “learn more” for program details. Compensation may be provided on a loadable debit card or by paper check in US dollars. The New Haven PCRU reserves the right to determine method of payment, determine eligibility, or change or terminate this program at any time.

Each clinical study has its own guidelines for who can participate, called eligibility criteria. However, only the research study staff can determine if you qualify to enroll in the study.

What to expect

If this study may be a fit for you, you’ll be invited to a screening visit at our facility in New Haven, CT. If you qualify for the study, there may be a period of up to 28 days before dosing.

If you choose to participate, you will stay at our facility for 12 consecutive overnights. Beginning the morning after admission, you will receive twice daily skin applications of the study drug or a placebo (no active ingredient) for 9 days and a final application on the 10th morning. This will be in the form of a cream or ointment. A follow-up call will be scheduled about 4 weeks after your last dose.

Throughout the study, staff will closely monitor your health status and collect data, such as the levels of the study drug in your blood.

Required overnight stays
12

A participant may be required to stay overnight at the PCRU for observation and study procedures. The number and length of overnight stays is determined by the design of the study.

Long-term follow up
1 phone-call

Some studies require the study team to stay in contact with the participant for a period of time after the participant completes the main part of the study. This long-term follow up is to collect additional information on the study drug over time.

How long is this study?
About 39 days

This is the time between admission and final follow-up call or visit. This does not include the time between screening and dosing, which can be up to 28 days.

Compensation
Up to $5,235 upon completion of the study

Participants in clinical trials at the PCRU receive financial compensation for their participation. The amount depends on factors like length of the stay, total number of study visits, and the nature of the study procedures.

All of the study procedures will be clearly explained to you during screening and can be viewed by downloading the informed consent form.

Safety remains our top priority at the PCRU during COVID-19
Learn about how we’re keeping participants and staff safe

Interested in participating?

Complete and submit this form, and a Pfizer New Haven Clinical Research Unit (PCRU) representative will contact you. Please note: volunteers completing this form must be able to read and speak English at an 8th grade level.

You may also call 1-800-254-6398 and speak with a PCRU representative to learn more.

For Japanese language assistance only, please call 1-833-711-9984. We apologize, our representatives cannot take calls in languages other than English or Japanese at this time.

The personal data gathered here will be collected, processed, and maintained in a confidential manner. Your information will be stored in our research unit’s database. We may use this information to invite you to participate in current and future clinical studies at the PCRU. You will have full access to your records at the Pfizer New Haven Clinical Research Unit and the opportunity to correct them if necessary.

Cancel